• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthmpox
Europe

Bavarian Nordic gearing up to produce 10 million doses of mpox vaccine as ‘further imported cases’ in Europe are coming, WHO warns

By
Camille Bas-Wohlert
Camille Bas-Wohlert
,
Marthe Bosuandole
Marthe Bosuandole
and
AFP
AFP
Down Arrow Button Icon
By
Camille Bas-Wohlert
Camille Bas-Wohlert
,
Marthe Bosuandole
Marthe Bosuandole
and
AFP
AFP
Down Arrow Button Icon
August 16, 2024, 5:17 AM ET
Bavarian Nordic said it is ready to produce up to 10 million doses of its vaccine targeting mpox by 2025.
Bavarian Nordic said it is ready to produce up to 10 million doses of its vaccine targeting mpox by 2025.Kobi Wolf—Bloomberg/Getty Images

The WHO on Thursday warned further imported cases of the new, more dangerous mpox strain in Europe were likely, after Sweden announced the first such infection outside Africa in an outbreak that has killed hundreds in the DR Congo.

The case recorded in a traveller in Sweden was announced the day after the World Health Organization declared the mpox surge in Africa a public health emergency of international concern — the highest alarm it can sound.

The UN health agency was concerned by the rise in cases and fatalities in the Democratic Republic of Congo, and the spread to Burundi, Kenya, Rwanda and Uganda.

Sweden’s Public Health Agency told AFP on Thursday that it had registered a case of the Clade 1b subclade — the same new strain of the virus that has surged in the DRC since September 2023.

“A person who sought care” in Stockholm “has been diagnosed with mpox caused by the clade 1 variant. It is the first case caused by clade I to be diagnosed outside the African continent,” the agency said in a separate statement.

The person was infected during a visit to “the part of Africa where there is a major outbreak of mpox Clade 1”, state epidemiologist Magnus Gisslen said in the statement.

The agency added: “The fact that a patient with mpox is treated in the country does not affect the risk to the general population, a risk that the European Centre for Disease Prevention and Control (ECDC) currently considers very low.”

The WHO’s European regional office in Copenhagen said it was discussing with Sweden how best to manage the newly detected case.

“The confirmation of mpox Clade 1 in Sweden is a clear reflection of the interconnectedness of our world,” it said in a statement.

“There are likely to be further imported cases of Clade 1 in the European region over the coming days and weeks, and it is imperative that we don’t stigmatise travellers or countries/regions.”

“Travel restrictions and border closures don’t work and should be avoided,” it added.

548 deaths in DRC

The outbreak has centred on the DR Congo.

Health Minister Samuel-Roger Kamba said in a video message that the country “has recorded 15,664 potential cases and 548 deaths since the beginning of the year”, with all 26 provinces affected.

The DRC’s population is around 100 million.

He said the government had put in place a “national strategic plan for vaccination against mpox”, as well as improving surveillance of the disease at borders and checkpoints.

The minister said government-level working groups have been set up to boost contact tracing and help mobilise resources to “maintain control of this epidemic”.

Formerly called monkeypox, the virus was discovered in 1958 in Denmark, in monkeys kept for research.

It was first discovered in humans in 1970 in what is now the DRC.

Mpox is an infectious disease caused by a virus transmitted to humans by infected animals but can also be passed from human to human through close physical contact.

The disease causes fever, muscular aches and large boil-like skin lesions.

Vaccine drive

The US Department of Health said Wednesday it would be “donating 50,000 doses of the Food and Drug Administration (FDA)-approved JYNNEOS vaccine to DRC”.

“Vaccination will be a critical element of the response to this outbreak,” it said in a statement.

And Danish drugmaker Bavarian Nordic said it was ready to produce up to 10 million doses of its vaccine targeting mpox by 2025.

There are two subtypes of the virus: the more virulent and deadlier Clade 1, endemic in the Congo Basin in central Africa; and Clade 2, endemic in West Africa.

In May 2022, mpox infections surged worldwide, mostly affecting gay and bisexual men, due to the Clade 2b subclade.

The WHO declared a public health emergency which lasted from July 2022 to May 2023.

That outbreak, which has now largely subsided, caused some 140 deaths out of around 90,000 cases.

The Clade 1b subclade causes more severe disease than Clade 2b, with a higher fatality rate.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Authors
By Camille Bas-Wohlert
See full bioRight Arrow Button Icon
By Marthe Bosuandole
See full bioRight Arrow Button Icon
By AFP
See full bioRight Arrow Button Icon

Latest in Health

HealthAffordable Care Act (ACA)
A Wisconsin couple was paying $2 a month for an ACA health plan. But as subsidies expire, it’s soaring to $1,600, forcing them to downgrade
By Ali Swenson and The Associated PressDecember 13, 2025
11 hours ago
Julian Braithwaite is the Director General of the International Alliance for Responsible Drinking
CommentaryProductivity
Gen Z is drinking 20% less than Millennials. Productivity is rising. Coincidence? Not quite
By Julian BraithwaiteDecember 13, 2025
12 hours ago
Nicholas Thompson
C-SuiteBook Excerpt
I took over one of the most prestigious media firms while training for an ultramarathon. Here’s what I learned becoming CEO of The Atlantic
By Nicholas ThompsonDecember 13, 2025
14 hours ago
Healthmeal delivery
Factor Meals Review 2025: Tester Approved
By Christina SnyderDecember 12, 2025
1 day ago
Donald Trump
HealthHealth Insurance
‘Tragedy in the making’: Top healthcare exec on why insurance will spike to subsidize a tax cut to millionaires and billionaires
By Nick LichtenbergDecember 12, 2025
1 day ago
HelloFresh meal delivery service.
Healthmeal delivery
HelloFresh Review : We Tasted Everything so You Don’t Have To
By Christina SnyderDecember 12, 2025
1 day ago

Most Popular

placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
2 days ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
1 day ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple CEO Tim Cook out-earns the average American’s salary in just 7 hours—to put that into context, he could buy a new $439,000 home in just 2 days
By Emma BurleighDecember 12, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.